Diagnosis of leishmaniasis

Leishmaniasis is a clinically heterogeneous syndrome caused by intracellular protozoan parasites of the genus Leishmania. The clinical spectrum of leishmaniasis encompasses subclinical ( not apparent), localized (skin lesion), and disseminated (cutaneous, mucocutaneous, and visceral) infection. This...

Full description

Saved in:
Bibliographic Details
Published inJournal of infection in developing countries Vol. 8; no. 8; pp. 961 - 972
Main Authors Elmahallawy, Ehab Kotb, Sampedro Martinez, Antonio, Rodriguez-Granger, Javier, Hoyos-Mallecot, Yannick, Agil, Ahamd, Navarro Mari, Jose Mari, Gutierrez Fernandez, Jose
Format Journal Article
LanguageEnglish
Published Italy Journal of Infection in Developing Countries 13.08.2014
The Journal of Infection in Developing Countries
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Leishmaniasis is a clinically heterogeneous syndrome caused by intracellular protozoan parasites of the genus Leishmania. The clinical spectrum of leishmaniasis encompasses subclinical ( not apparent), localized (skin lesion), and disseminated (cutaneous, mucocutaneous, and visceral) infection. This spectrum of manifestations depends on the immune status of the host, on the parasite, and on immunoinflammatory responses. Visceral leishmaniasis causes high morbidity and mortality in the developing world. Reliable laboratory methods become mandatory for accurate diagnosis, especially in immunocompromised patients such as those infected with HIV. In this article, we review the current state of the diagnostic tools for leishmaniasis, especially  the serological test.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:1972-2680
2036-6590
1972-2680
DOI:10.3855/jidc.4310